Work

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease

Year: 2020
Type: article
Abstract: This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
Language: English
Subfield: Parasitology
Open Access status: bronze
Funders: National Science Foundation, U.S. Department of Defense, U.S. Department of Health and Human Services, Alzheimer's Association, George Gund Foundation, Abbott Laboratories, China Medical Board, Fisher Center for Alzheimer's Research Foundation, Charles H. Hood Foundation, Amgen, Bristol-Myers Squibb, Lyme Disease Association, Pfizer, GlaxoSmithKline, Sanofi, Baxter International, New York State Department of Health, Yale University, Gilead Sciences, Biogen, Heart Rhythm Society, Teva Pharmaceutical Industries, Infectious Diseases Society of America, Harvard Catalyst, Michigan State University, Alere, Johns Hopkins University, Boston Scientific Corporation, American Gastroenterological Association, Michigan Department of Health and Human Services, G. Harold and Leila Y. Mathers Foundation, Children's Hospitals and Clinics of Minnesota, Bay Area Lyme Foundation, Global Lyme Alliance, Atara Biotherapeutics, BioFire Diagnostics, Horizon Therapeutics, Association of Medical Microbiology and Infectious Disease Canada, European Society of Clinical Microbiology and Infectious Diseases, Javna Agencija za Raziskovalno Dejavnost RS, Shionogi, Vancouver Coastal Health Research Institute, Ministrstvo za zdravje, National Institutes of Health, Centers for Disease Control and Prevention, Genentech, EMD Serono, Centers for Medicare and Medicaid Services, College of Engineering, Michigan State University, Center for AIDS Research, University of Washington, Takeda Oncology, Pfizer Canada, Canadian Institutes of Health Research, National Center for Advancing Translational Sciences
Award: N/A
OpenAlex ID: W4232954635
FWCI: 28.33
Cites: 403
Cited by: 378
Related to: 10